CIK 0001581280 · Large accelerated filer
Twist Bioscience Corp
Sign in to watch- Ticker
- TWST
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 462058888
- Phone
- 800-719-0671
- Business address
- 681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA, 94080
- 4 Open-market sale SVP of Human Resources sold 907 shares at $122.62 ($111,220)
- 4 Open-market sale Chief Executive Officer sold 2,302 shares at $122.62 ($282,280)
- 4 Open-market sale Chief Accounting Officer sold 238 shares at $122.62 ($29,185)
- 4 Planned sale Chief Executive Officer sold 41,570 shares at an average $151.98 ($6,317,760)
- 4 Open-market sale See Remarks sold 1,598 shares at $139.07 ($222,227)
- 4 Open-market sale President and COO sold 4,046 shares at $139.07 ($562,661)
- 4 Open-market sale SVP of Human Resources sold 1,360 shares at $139.07 ($189,130)
- 4 Open-market sale Chief Financial Officer sold 1,965 shares at $139.07 ($273,265)
- 4 Open-market sale Chief Executive Officer sold 6,639 shares at $139.07 ($923,259)
- 4 Open-market sale Chief Accounting Officer sold 1,523 shares at an average $140.02 ($213,255)
- 4 Planned sale See Remarks sold 14,205 shares at $129.75 ($1,843,099)
- 4 Planned sale President and COO sold 78,355 shares at an average $117.64 ($9,217,607)
- 4 Open-market sale Director sold 2,240 shares at $122.88 ($275,251)
- 4 Planned sale Chief Executive Officer sold 19,952 shares at $125.08 ($2,495,508)
- 4 Planned sale Chief Executive Officer sold 113,318 shares at $125.16 ($14,183,051)
- 4 Planned sale Director sold 18,417 shares at $110.89 ($2,042,261)
- 4 Planned sale See Remarks sold 14,205 shares at $109.75 ($1,558,999)
- 4 Open-market sale President and COO sold 2,888 shares at $85.32 ($246,408)
- 4 Open-market sale SVP of Human Resources sold 1,133 shares at $85.32 ($96,669)
- 4 Open-market sale Chief Executive Officer sold 5,101 shares at $85.32 ($435,223)
Page 2 of 51 · 1,011 filings